Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

After analyzing treatment patterns in chronic lymphocytic leukemia (CLL) (objective 1), we investigated the relative effectiveness of ibrutinib versus other commonly used treatments (objective 2) in patients with treatment-naïve and relapsed/refractory CLL, comparing patient-level data from two rand...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hematol
Main Authors: Salles, Gilles, Bachy, Emmanuel, Smolej, Lukas, Simkovic, Martin, Baseggio, Lucile, Panovska, Anna, Besson, Hervé, Healy, Nollaig, Garside, Jamie, Iraqi, Wafae, Diels, Joris, Pick-Lauer, Corinna, Spacek, Martin, Urbanova, Renata, Lysak, Daniel, Hermans, Ruben, Lundbom, Jessica, Callet-Bauchu, Evelyne, Doubek, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900267/
https://ncbi.nlm.nih.gov/pubmed/31745601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-019-03830-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados